Anti-Red Tape Authority (ARTA) director general Jeremiah Belgica said the Food and Drug Administration (FDA) has the ability to accelerate the process of registration of coronavirus disease 2019 (Covid-19) vaccine once it is available here.
During the Laging Handa briefing Tuesday, Belgica said the streamlining of processes at FDA will ensure timely delivery of Covid-19 vaccines and other medicines to fight the coronavirus.
He added that FDA started the streamlining of its processes in 2019.
“They have started the full automation of their services. We are reminding (the) FDA that the registration process for certificate of product registration should not exceed 20 days processing time,” he said in Filipino.
Belgica said since the certificate of product registration is a highly technical transaction, the Ease of Doing Business (EODB) and Efficient Delivery of Government Service Act of 2018 is allotted 20 days of processing time.
He added the FDA can still request for additional 20 days if they have reasonable basis for extension.
“FDA is a critical agency,” Belgica said. “That’s why streamlining their processes is one of the priorities of ARTA
Source: Philippines News agency